Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry
- PMID: 3819786
- DOI: 10.1007/BF00314009
Ultrastructural localization of glucocerebrosidase in cultured Gaucher's disease fibroblasts by immunocytochemistry
Abstract
The subcellular localization of glucocerebrosidase was studied in cultured skin fibroblasts from eight patients with Gaucher's disease. The enzyme, in situ, was visualized under the electron microscope by incubating ultrathin frozen sections of fibroblasts with antibodies against glucocerebrosidase, followed by a second incubation with goat anti- (rabbit IgG) coupled to colloidal gold. In control cells, most of the gold label was found in lysosomes, associated with the membrane. Labelling of the rough endoplasmic reticulum (RER) and Golgi complex was also observed. In fibroblasts from three Gaucher's disease patients without neurological symptoms (type 1 disease), a near normal amount of cross-reactive material (CRM) was detected in lysosomes, but in a fourth such patient, the lysosomal CRM was reduced. Little lysosomal glucocerebrosidase was detected in cells from patients with the acute neuronopathic form (type 2) or the subacute neuronopathic form (type 3) of Gaucher's disease. CRM in lysosomes correlates with amount of mature, 59 kDA glucocerebrosidase which is undetectable in type 2 and type 3 Gaucher's disease cell lines. These findings demonstrate that different mutations in the gene for glucocerebrosidase result in mutant proteins that have different intracellular localizations. They also suggest that there is a relationship between the amount of cross-reactive material in the lysosomes and the phenotypic expression of the disease.
Similar articles
-
Determination of Gaucher's disease phenotypes with monoclonal antibody.Clin Chim Acta. 1983 Jul 15;131(3):283-7. doi: 10.1016/0009-8981(83)90097-9. Clin Chim Acta. 1983. PMID: 6883722
-
An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen.Ultrastruct Pathol. 1988 Sep-Oct;12(5):471-8. doi: 10.3109/01913128809032232. Ultrastruct Pathol. 1988. PMID: 3194992
-
Molecular weight characterization of beta-D-glucocerebrosidase in mononuclear white blood cells in Gaucher's disease.Biochem Med. 1984 Feb;31(1):73-9. doi: 10.1016/0006-2944(84)90061-9. Biochem Med. 1984. PMID: 6743300
-
Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.Mov Disord. 2016 Nov;31(11):1610-1618. doi: 10.1002/mds.26802. Epub 2016 Sep 13. Mov Disord. 2016. PMID: 27619775 Free PMC article. Review.
-
Mammalian glucocerebrosidase: implications for Gaucher's disease.Lab Invest. 1988 Jan;58(1):5-25. Lab Invest. 1988. PMID: 3275832 Review. No abstract available.
Cited by
-
Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.Am J Hum Genet. 1991 Sep;49(3):646-55. Am J Hum Genet. 1991. PMID: 1909090 Free PMC article.
-
A biochemical and immunocytochemical study on the targeting of alglucerase in murine liver.Histochem J. 1995 Aug;27(8):639-46. Histochem J. 1995. PMID: 8550385
-
The N370S (Asn370-->Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C.Biochem J. 2005 Aug 15;390(Pt 1):95-103. doi: 10.1042/BJ20050325. Biochem J. 2005. PMID: 15826241 Free PMC article.
-
Mammalian Golgi-associated Bicaudal-D2 functions in the dynein-dynactin pathway by interacting with these complexes.EMBO J. 2001 Aug 1;20(15):4041-54. doi: 10.1093/emboj/20.15.4041. EMBO J. 2001. PMID: 11483508 Free PMC article.
-
Are we listening to everything the PARK genes are telling us?J Comp Neurol. 2019 May 15;527(9):1527-1540. doi: 10.1002/cne.24642. Epub 2019 Feb 8. J Comp Neurol. 2019. PMID: 30680728 Free PMC article. Review.